These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3184607)

  • 1. Early functional effects of various antihypertensive drugs in chronically uremic rats.
    Teschner M; Bahner U; Schaefer RM; Möslein J; Heidland A
    Kidney Int Suppl; 1988 Sep; 25():S156-9. PubMed ID: 3184607
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acidosis and the elevated anion gap (I).
    Narins RG; Rudnick MR; Bastl CP
    Hosp Pract; 1980 May; 15(5):125-9, 133-6. PubMed ID: 6768669
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrocyte adenosine triphosphate depletion during hypophosphatemia in a uremic subject.
    Lichtman MA; Miller DR; Freeman RB
    N Engl J Med; 1969 Jan; 280(5):240-4. PubMed ID: 4236189
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth hormone action is blunted by acidosis in experimental uremia or acid load.
    Maniar S; Kleinknecht C; Zhou X; Motel V; Yvert JP; Dechaux M
    Clin Nephrol; 1996 Jul; 46(1):72-6. PubMed ID: 8832158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of acetate and bicarbonate in the treatment of uremic acidosis.
    Feng PH; Weinberg U; Reisin E; Iaina A; Eliahou HE
    Isr J Med Sci; 1970; 6(6):732-4. PubMed ID: 5512593
    [No Abstract]   [Full Text] [Related]  

  • 7. Parathyroid acidosis in uraemia.
    Muldowney FP; Donohoe JF; Carroll DV; Powell D; Freaney R
    Q J Med; 1972 Jul; 41(163):321-42. PubMed ID: 5072056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Malignant arterial hypertension. Intensive treatment by acute sodium depletion and antihypertensive agents].
    Baglin A; Safar M; Milliez P
    Nouv Presse Med; 1972 Jan; 1(5):299-304. PubMed ID: 5010444
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
    Azzadin A; Małyszko J; Małyszko JS; Tankiewicz A; Myśliwiec M; Buczko W
    Pol J Pharmacol; 2002; 54(5):469-73. PubMed ID: 12593533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kidney as a target organ in antihypertensive treatment.
    Aurell M
    Scand J Urol Nephrol Suppl; 1988; 108():7-12. PubMed ID: 3163834
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
    Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
    Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of metabolic acidosis in patients with chronic renal insufficiency].
    Oechslen D; Weingard D; Kluthe R
    Med Klin; 1971 Apr; 66(14):518-21. PubMed ID: 5552238
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum chloride and bicarbonate levels in chronic renal failure.
    Luke RG
    Arch Intern Med; 1979 Oct; 139(10):1091-2. PubMed ID: 485737
    [No Abstract]   [Full Text] [Related]  

  • 14. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic renal failure with metabolic acidosis on alanine metabolism in isolated liver cells.
    Cano N; Sturm JM; Meijer AJ; El-Mir MY; Novaretti R; Reynier JP; Leverve XM
    Clin Nutr; 2004 Jun; 23(3):317-24. PubMed ID: 15158294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antihypertensive drugs in the therapy of patients on regular dialysis treatment.
    Sulková S; Válek A
    Kidney Int Suppl; 1988 Sep; 25():S198-200. PubMed ID: 3184612
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive effects of metolazone (zaroxolyn).
    Materson BJ; Oster JR; Perez-Stable EC
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):890-6. PubMed ID: 4214663
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical considerations in the treatment of arterial hypertension.
    Finnerty FA
    Mod Concepts Cardiovasc Dis; 1973 Aug; 42(8):37-40. PubMed ID: 4784808
    [No Abstract]   [Full Text] [Related]  

  • 19. Diet and drugs in renal acidosis and acid-base regulation.
    Irvine RO
    Prog Biochem Pharmacol; 1972; 7():146-88. PubMed ID: 4567417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antihypertensive therapy in early stages of chronic kidney disease. Second and third stages of chronic kidney disease].
    Gorostidi M; Marín R;
    Nefrologia; 2004; 24 Suppl(6):91-100, 187-235. PubMed ID: 15696900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.